CYRX

Cryoport, Inc. · NASDAQ · Industrials · USD · 10-K for 2025, filed 2026-03-05

Figures on this page computed 2026-11-08 12:48 UTC

Last close

16.70USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-05

  • 13.6xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-03-05

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-05
    • 10-K for 2025, filed 2026-03-05
    • 10-K for 2025, filed 2026-03-05
    • 10-Q for 2025, filed 2026-08-06
    • 10-K for 2025, filed 2026-03-05
    • 10-Q for 2025, filed 2026-08-06

    The filing itself

  • 44.4%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-05
    • 10-K for 2025, filed 2026-03-05

    The filing itself

  • -14.2%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-05
    • 10-K for 2025, filed 2026-03-05

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-05
    • 10-Q for 2025, filed 2026-08-06

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

What it sells, to whom

lens 8 of 9

What it sells

2
Life Sciences Services102,145,000 UNIT_STAND57.4%
Life Sciences Products75,771,000 UNIT_STAND42.6%

Where it sells it

3
Americas131,260,000 USD74.5%
EMEA25,134,000 USD14.3%
Asia Pacific19,783,000 USD11.2%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

2 segments, 3 places and 0 named customers, each as the filer published it.

2 segments, 3 places and 0 named customers, each as the filer published it.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-05

  • Life Sciences Services102,145,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    UNIT_STAND

    The filing itself

  • Life Sciences Products75,771,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    UNIT_STAND

    The filing itself

  • Americas131,260,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD

    The filing itself

  • EMEA25,134,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD

    The filing itself

  • Asia Pacific19,783,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0001104659-26-024180
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.